A detailed history of Redpoint Investment Management Pty LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 2,549 shares of REGN stock, worth $1.93 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
2,549
Previous 3,123 18.38%
Holding current value
$1.93 Million
Previous $1.85 Million 4.88%
% of portfolio
0.26%
Previous 0.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022

SELL
$573.97 - $724.32 $329,458 - $415,759
-574 Reduced 18.38%
2,549 $1.76 Million
Q1 2022

Apr 13, 2022

SELL
$595.12 - $698.43 $28,565 - $33,524
-48 Reduced 1.51%
3,123 $2.18 Million
Q4 2021

Jan 19, 2022

BUY
$543.48 - $670.97 $59,782 - $73,806
110 Added 3.59%
3,171 $2 Million
Q3 2021

Nov 12, 2021

SELL
$574.03 - $680.96 $107,917 - $128,020
-188 Reduced 5.79%
3,061 $1.85 Million
Q2 2021

Aug 05, 2021

SELL
$472.8 - $558.54 $124,819 - $147,454
-264 Reduced 7.51%
3,249 $1.82 Million
Q1 2021

Apr 13, 2021

BUY
$446.73 - $548.2 $89,346 - $109,640
200 Added 6.04%
3,513 $1.66 Million
Q4 2020

Jan 13, 2021

BUY
$478.3 - $607.98 $373,552 - $474,832
781 Added 30.85%
3,313 $1.6 Million
Q3 2020

Oct 09, 2020

SELL
$544.75 - $658.21 $1.76 Million - $2.13 Million
-3,230 Reduced 56.06%
2,532 $1.42 Million
Q2 2020

Jul 17, 2020

SELL
$493.32 - $643.92 $163,782 - $213,781
-332 Reduced 5.45%
5,762 $3.59 Million
Q2 2019

Aug 07, 2019

SELL
$299.6 - $414.82 $263,348 - $364,626
-879 Reduced 12.61%
6,094 $1.91 Million
Q1 2019

May 14, 2019

BUY
$372.08 - $439.57 $490,029 - $578,913
1,317 Added 23.29%
6,973 $2.86 Million
Q4 2017

Aug 09, 2018

BUY
$358.63 - $469.95 $2.03 Million - $2.66 Million
5,656
5,656 $2.13 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Redpoint Investment Management Pty LTD Portfolio

Follow Redpoint Investment Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.